J. Ganjei
Vermögen: 29 003 $ am 30.06.2026
Vermögen: 29 003 $ am 30.06.2026
J.
Kelly Ganjei was the founder of RemeGenix, Inc., founded in 2006, where the title held was President, Chief Executive Officer & Director.
Mr. Ganjei is the founder of Amplifybio LLC, founded in 2025, holding the title of Chief Executive Officer.
Mr. Ganjei is also the founder of Kappa Lifescience Ltd.,Sienagen S R L..
Mr. Ganjei currently serves as Chairman & Chief Executive Officer at Cognate BioServices, Inc. since 2011.
Mr. Ganjei is Chairman at INmune Bio, Inc. starting in 2025.
Former positions include Chairman & Chief Executive Officer at Fortress Biotech, Inc., Director at Alzheimer’s Association, Vice President-Business Development at Kolon TissueGene, Inc. from 2001 to 2007, Principal at US Small Business Administration, and Manager-Business Development & Global Informatics at LabVantage Solutions, Inc. from 2001 to 2004.
Education includes undergraduate studies at George Washington University and undergraduate degree conferred in 1995 from the University of Maryland.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
INMUNE BIO, INC. 0.07% | 20.04.2026 | 17’793 ( 0.07% ) | 29 003 $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| INMUNE BIO INC. | Vorsitzender | 07.08.2025 |
Cognate BioServices, Inc.
Cognate BioServices, Inc. BiotechnologyHealth Technology Manufactures cell-based therapeutics products | Vorstandsvorsitzender | 01.01.2011 |
Kappa Lifescience Ltd. | Vorstandsvorsitzender | - |
Sienagen S R L | Vorstandsvorsitzender | - |
Amplifybio LLC
Amplifybio LLC Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology research organization | Vorstandsvorsitzender | 01.10.2025 |
| Unternehmen | Position | Ende |
|---|---|---|
| KOLON TISSUEGENE, INC. | Corporate Officer/Principal | 01.02.2007 |
LabVantage Solutions, Inc.
LabVantage Solutions, Inc. Packaged SoftwareTechnology Services Provides enterprise laboratory software solutions | Corporate Officer/Principal | 01.01.2004 |
| FORTRESS BIOTECH, INC. | Vorstandsvorsitzender | - |
US Small Business Administration
US Small Business Administration Finance/Rental/LeasingFinance Provides funding and support to entrepreneurs and small businesses | Corporate Officer/Principal | - |
| ░░░░░░░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 13 |
|---|---|
Fortress Biotech, Inc.
Fortress Biotech, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical and biotechnology products | Health Technology |
George Washington University
George Washington University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kolon TissueGene, Inc.
Kolon TissueGene, Inc. Medical SpecialtiesHealth Technology Provides orthopedic therapeutic products | Health Technology |
US Small Business Administration
US Small Business Administration Finance/Rental/LeasingFinance Provides funding and support to entrepreneurs and small businesses | Finance |
University of Maryland
University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
LabVantage Solutions, Inc.
LabVantage Solutions, Inc. Packaged SoftwareTechnology Services Provides enterprise laboratory software solutions | Technology Services |
Cognate BioServices, Inc.
Cognate BioServices, Inc. BiotechnologyHealth Technology Manufactures cell-based therapeutics products | Health Technology |
Alzheimer’s Association
Alzheimer’s Association Miscellaneous Commercial ServicesCommercial Services Noncommercial Research Organizations | Commercial Services |
RemeGenix, Inc.
RemeGenix, Inc. Pharmaceuticals: MajorHealth Technology Operates as a development stage biotechnology company | Health Technology |
INmune Bio, Inc.
INmune Bio, Inc. BiotechnologyHealth Technology Develops therapies that harness the patient's immune system to treat cancer | Health Technology |
Kappa Lifescience Ltd. | |
Sienagen S R L | |
Amplifybio LLC
Amplifybio LLC Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology research organization | Commercial Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen